The Outcome of COVID-19 in Pediatric-Onset Multiple Sclerosis Patients

BACKGROUND: The pathogenesis of multiple sclerosis (MS) involves immune-mediated mechanisms, and disease-modifying therapies (DMTs) administered in MS have immunomodulatory effects. The concern about MS patients' susceptibility to coronavirus disease 2019 (COVID-19) has prompted several studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Oncel, Ibrahim, Alici, Nurettin, Solmaz, Ismail, Oge, Dogan Dinc, Ozsurekci, Yasemin, Anlar, Banu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186527/
https://www.ncbi.nlm.nih.gov/pubmed/35772229
http://dx.doi.org/10.1016/j.pediatrneurol.2022.06.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186527/
https://www.ncbi.nlm.nih.gov/pubmed/35772229
http://dx.doi.org/10.1016/j.pediatrneurol.2022.06.004

Ejemplares similares